The pharmacological profile of ovalbumin-induced paw oedema in rats

Rats are commonly used in anaphylaxis models, mainly in intestinal anaphylaxis. Hypersensitivity mechanisms are complex and they are not clearly defined. Ovalbumin (OVA) is commonly used for studies on the hypersensitivity mechanism. However, the potential pro-inflammatory mediators induced by this...

Full description

Saved in:
Bibliographic Details
Main Authors: R. F. G. Feitosa, G. B. Melcíades, A. M. S. Assreuy, M. F. G. Rocha, R. A. Ribeiro, A. A. M. Lima
Format: Article
Language:English
Published: Wiley 2002-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1080/09622935020138000
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850176146938789888
author R. F. G. Feitosa
G. B. Melcíades
A. M. S. Assreuy
M. F. G. Rocha
R. A. Ribeiro
A. A. M. Lima
author_facet R. F. G. Feitosa
G. B. Melcíades
A. M. S. Assreuy
M. F. G. Rocha
R. A. Ribeiro
A. A. M. Lima
author_sort R. F. G. Feitosa
collection DOAJ
description Rats are commonly used in anaphylaxis models, mainly in intestinal anaphylaxis. Hypersensitivity mechanisms are complex and they are not clearly defined. Ovalbumin (OVA) is commonly used for studies on the hypersensitivity mechanism. However, the potential pro-inflammatory mediators induced by this antigen in the model of paw oedema in immunized rats are still not completely understood. This work examines the pharmacological modulation of several mediators involved in rat hind paw immune oedema induced by OVA. Wistar rats were previously immunized (14-18 days) with OVA (30 μg, intraperitoneally) or sham-sensitized with aluminum hydroxide (control). The paw volumes were measured before the antigenic stimuli and 1, 2, 3 and 4 h after the intraplantar injection of OVA (10 μg/paw). Subcutaneous injection of dexamethasone, diphenhydramine, cyproheptadine, chlorpromazine or methysergide significantly inhibited (p<0.05) the allergic paw oedema. The dual inhibitor of cyclooxygenase and lipoxygenase (NDGA), the cyclooxygenase inhibitor (indomethacin), the lipoxygenase inhibitor (MK-886), the PAF antagonist (WEB 2086), the mast cell stabilizer (ketotifen), and the anti-histamine (meclizine) did not inhibit the immune oedema. In addition, thalidomide and pentoxifylline (anti-tumour necrosis factor drugs) were ineffective against OVA-induced oedema. The fact that indomethacin, MK-886, NDGA and WEB 2086 are unable to inhibit this allergic oedema indicates that the dexamethasone action seems not to be via phospholipase A2, but possibly due to the synthesis and/or the inhibitory activity of cytokines. The paw oedema inhibition by diphenhydramine, but not by meclizine, may suggest a different mechanism, which is independent of the effect of histamine. These data indicate that allergic oedema is more sensitive to anti-serotonin drugs, mainly anti-5-HT2, suggesting that the principal mediator of this inflammatory response is serotonin.
format Article
id doaj-art-b749cd9eccf242bf9357cc62262c2e5f
institution OA Journals
issn 0962-9351
1466-1861
language English
publishDate 2002-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-b749cd9eccf242bf9357cc62262c2e5f2025-08-20T02:19:19ZengWileyMediators of Inflammation0962-93511466-18612002-01-0111315516310.1080/09622935020138000The pharmacological profile of ovalbumin-induced paw oedema in ratsR. F. G. Feitosa0G. B. Melcíades1A. M. S. Assreuy2M. F. G. Rocha3R. A. Ribeiro4A. A. M. Lima5Institute of Biomedicine, Clinical Research Unit, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Av. José Bastos 3390, Fortaleza, CE CEP 60436–160, BrazilFaculty of Veterinary Science, CCS, State University of Ceara, Fortaleza, CE, BrazilDepartment of Physiological Sciences, CCS, State University of Ceara, Fortaleza, CE, BrazilFaculty of Veterinary Science, CCS, State University of Ceara, Fortaleza, CE, BrazilInstitute of Biomedicine, Clinical Research Unit, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Av. José Bastos 3390, Fortaleza, CE CEP 60436–160, BrazilInstitute of Biomedicine, Clinical Research Unit, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Av. José Bastos 3390, Fortaleza, CE CEP 60436–160, BrazilRats are commonly used in anaphylaxis models, mainly in intestinal anaphylaxis. Hypersensitivity mechanisms are complex and they are not clearly defined. Ovalbumin (OVA) is commonly used for studies on the hypersensitivity mechanism. However, the potential pro-inflammatory mediators induced by this antigen in the model of paw oedema in immunized rats are still not completely understood. This work examines the pharmacological modulation of several mediators involved in rat hind paw immune oedema induced by OVA. Wistar rats were previously immunized (14-18 days) with OVA (30 μg, intraperitoneally) or sham-sensitized with aluminum hydroxide (control). The paw volumes were measured before the antigenic stimuli and 1, 2, 3 and 4 h after the intraplantar injection of OVA (10 μg/paw). Subcutaneous injection of dexamethasone, diphenhydramine, cyproheptadine, chlorpromazine or methysergide significantly inhibited (p<0.05) the allergic paw oedema. The dual inhibitor of cyclooxygenase and lipoxygenase (NDGA), the cyclooxygenase inhibitor (indomethacin), the lipoxygenase inhibitor (MK-886), the PAF antagonist (WEB 2086), the mast cell stabilizer (ketotifen), and the anti-histamine (meclizine) did not inhibit the immune oedema. In addition, thalidomide and pentoxifylline (anti-tumour necrosis factor drugs) were ineffective against OVA-induced oedema. The fact that indomethacin, MK-886, NDGA and WEB 2086 are unable to inhibit this allergic oedema indicates that the dexamethasone action seems not to be via phospholipase A2, but possibly due to the synthesis and/or the inhibitory activity of cytokines. The paw oedema inhibition by diphenhydramine, but not by meclizine, may suggest a different mechanism, which is independent of the effect of histamine. These data indicate that allergic oedema is more sensitive to anti-serotonin drugs, mainly anti-5-HT2, suggesting that the principal mediator of this inflammatory response is serotonin.http://dx.doi.org/10.1080/09622935020138000
spellingShingle R. F. G. Feitosa
G. B. Melcíades
A. M. S. Assreuy
M. F. G. Rocha
R. A. Ribeiro
A. A. M. Lima
The pharmacological profile of ovalbumin-induced paw oedema in rats
Mediators of Inflammation
title The pharmacological profile of ovalbumin-induced paw oedema in rats
title_full The pharmacological profile of ovalbumin-induced paw oedema in rats
title_fullStr The pharmacological profile of ovalbumin-induced paw oedema in rats
title_full_unstemmed The pharmacological profile of ovalbumin-induced paw oedema in rats
title_short The pharmacological profile of ovalbumin-induced paw oedema in rats
title_sort pharmacological profile of ovalbumin induced paw oedema in rats
url http://dx.doi.org/10.1080/09622935020138000
work_keys_str_mv AT rfgfeitosa thepharmacologicalprofileofovalbumininducedpawoedemainrats
AT gbmelciades thepharmacologicalprofileofovalbumininducedpawoedemainrats
AT amsassreuy thepharmacologicalprofileofovalbumininducedpawoedemainrats
AT mfgrocha thepharmacologicalprofileofovalbumininducedpawoedemainrats
AT raribeiro thepharmacologicalprofileofovalbumininducedpawoedemainrats
AT aamlima thepharmacologicalprofileofovalbumininducedpawoedemainrats
AT rfgfeitosa pharmacologicalprofileofovalbumininducedpawoedemainrats
AT gbmelciades pharmacologicalprofileofovalbumininducedpawoedemainrats
AT amsassreuy pharmacologicalprofileofovalbumininducedpawoedemainrats
AT mfgrocha pharmacologicalprofileofovalbumininducedpawoedemainrats
AT raribeiro pharmacologicalprofileofovalbumininducedpawoedemainrats
AT aamlima pharmacologicalprofileofovalbumininducedpawoedemainrats